Promoter Polymorphisms of Pri-miR-34b/c Are Associated with Hepatocellular Carcinoma
Overview
Authors
Affiliations
Background: Numerous studies have focused on the association between miR-34 family members, which are direct p53 targets, and carcinogenesis of many cancers, including hepatocellular carcinoma (HCC). This study aimed to assess whether polymorphisms in the single-nucleotide polymorphism miR-34b/c T>C (rs4938723) and TP53 Arg72Pro (rs1042522) increase the risk of HCC and influence outcome in patients with HCC.
Patients And Methods: We enrolled 157 HCC patients and 201 cancer-free control subjects from the Korean population. MicroRNA polymorphisms were genotyped using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
Results: We found that the miR-34b/c TC+CC frequency was significantly higher in HCC patients than in controls (adjusted odds ratio [AOR]: 1.580; 95% confidence interval [CI]: 1.029-2.426). The miR-34b/c CC-TP53 Arg/Arg combination significantly increased the risk of HCC (AOR: 13.644; 95% CI: 1.451-128.301). The SNPs miR-34b/c T>C and TP53 Arg72Pro(G>C) had no influence on survival of HCC patients.
Conclusions: Our findings suggest that loss of the T allele in miR-34b/c T>C, and the miR-34b/c CC-TP53 Arg/Arg combination increases the risk of HCC in the Korean population.
Toscano-Guerra E, Maggio V, Garcia J, Semidey M, Celma A, Morote J Front Oncol. 2024; 14:1398411.
PMID: 39193388 PMC: 11347290. DOI: 10.3389/fonc.2024.1398411.
MicroRNA-34 and gastrointestinal cancers: a player with big functions.
Gao W, Zhou J, Morshedi M Cancer Cell Int. 2024; 24(1):163.
PMID: 38725047 PMC: 11084024. DOI: 10.1186/s12935-024-03338-w.
MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.
Mendiola-Soto D, Barcenas-Lopez D, Perez-Amado C, Cruz-Miranda G, Mejia-Arangure J, Ramirez-Bello J Int J Mol Sci. 2023; 24(6).
PMID: 36982511 PMC: 10049736. DOI: 10.3390/ijms24065436.
Analysis of Rare Alleles of and as a Prognostic Marker in Thyroid Cancer in Pakistani Population.
Khan R, Abbasi S, Mansoor Q, Ahmed M, Mir K, Baig R Diagnostics (Basel). 2022; 12(10).
PMID: 36292185 PMC: 9600261. DOI: 10.3390/diagnostics12102495.
Mechanisms Controlling MicroRNA Expression in Tumor.
Chen S, Wang Y, Li D, Wang H, Zhao X, Yang J Cells. 2022; 11(18).
PMID: 36139427 PMC: 9496884. DOI: 10.3390/cells11182852.